These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8691987)

  • 21. Muscarinic receptor binding and behavioral effects of atropoine following chronic catecholamine depletion or acetylcholinesterase inhibition in rats.
    Schallert T; Overstreet DH; Yamamura HI
    Pharmacol Biochem Behav; 1980 Aug; 13(2):187-92. PubMed ID: 7413689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation by chronic drug administration of neuronal and cardiac calcium channel, beta-adrenoceptor and muscarinic receptor levels.
    Gengo P; Skattebøl A; Moran JF; Gallant S; Hawthorn M; Triggle DJ
    Biochem Pharmacol; 1988 Feb; 37(4):627-33. PubMed ID: 2449216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors.
    Van de Kamp JL; Collins AC
    Pharmacol Biochem Behav; 1992 May; 42(1):131-41. PubMed ID: 1528936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental changes in beta-adrenoceptors, muscarinic cholinoceptors and Ca2+ channels in rat ventricular muscles.
    Kojima M; Ishima T; Taniguchi N; Kimura K; Sada H; Sperelakis N
    Br J Pharmacol; 1990 Feb; 99(2):334-9. PubMed ID: 2158375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate.
    Bushnell PJ; Padilla SS; Ward T; Pope CN; Olszyk VB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):741-50. PubMed ID: 1994004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The reversal effect of insulin on diabetes-induced alterations in beta adrenergic and muscarinic receptors in rat prostate.
    Fukumoto Y; Yoshida M; Dokita S; Kamai T; Weiss RM; Latifpour J
    J Urol; 1993 Jun; 149(6):1602-6. PubMed ID: 8388963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha 1- and beta-adrenergic and muscarinic cholinergic receptors in guinea-pig nasal mucosa.
    Ishibe T; Kuno T; Tanaka C
    Eur J Pharmacol; 1984 Oct; 106(1):107-12. PubMed ID: 6099264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-tolerance between muscarinic agonists: role of muscarinic receptors.
    Collins AC; Smolen TN; Smolen A; Medhurst LJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):173-82. PubMed ID: 3562489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of chemical sympathectomy with 6-hydroxydopamine on alpha- and beta-adrenoceptors and muscarinic cholinoceptors in rat kidney.
    Yamada S; Yamamura HI; Roeske WR
    Eur J Pharmacol; 1986 Mar; 121(3):345-53. PubMed ID: 3009209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of bladder beta-adrenergic and muscarinic cholinergic receptors in experimental diabetes.
    Latifpour J; Nishimoto T; Marian MJ; Yoshida M; Weiss RM
    Diabetes; 1991 Sep; 40(9):1150-6. PubMed ID: 1657672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of memory by a cholinesterase inhibitor associated with muscarinic receptor down-regulation.
    Lerer B; Altman H; Stanley M
    Pharmacol Biochem Behav; 1984 Sep; 21(3):467-9. PubMed ID: 6494217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase.
    Bushnell PJ; Pope CN; Padilla S
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1007-17. PubMed ID: 7689099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of chronic lithium pretreatment on rat brain muscarinic receptor regulation.
    Levy A; Zohar J; Belmaker RH
    Neuropharmacology; 1982 Nov; 21(11):1199-201. PubMed ID: 7177345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic, low-level exposure to the cholinesterase inhibitor DFP. I. Time course of neurochemical changes in the rat pontomesencephalic tegmentum.
    Deurveilher S; Delamanche IS; Hars B; Breton P; Hennevin E
    Pharmacol Biochem Behav; 1999 Sep; 64(1):95-103. PubMed ID: 10495003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP; Posner P
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional adaptation of muscarinic receptors and choline uptake in brain following repeated administration of diisopropylfluorophosphate and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    Brain Res; 1983 Jun; 268(2):315-20. PubMed ID: 6871685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscarinic receptor plasticity in the brain of senescent rats: down-regulation after repeated administration of diisopropyl fluorophosphate.
    Pintor A; Fortuna S; Volpe MT; Michalek H
    Life Sci; 1988; 42(21):2113-21. PubMed ID: 3386396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased diisopropylfluorophosphate-induced toxicity in mu-opioid receptor knockout mice.
    Tien LT; Fan LW; Ma T; Loh HH; Ho IK
    J Neurosci Res; 2004 Oct; 78(2):259-67. PubMed ID: 15378609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha- and beta-adrenergic and muscarinic cholinergic binding sites in the bladder and urethra of the rabbit.
    Johns A
    Can J Physiol Pharmacol; 1983 Jan; 61(1):61-6. PubMed ID: 6301661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.